Uncategorized

Hemostat Powder and Hemostatic Agents Market, Global Outlook and Forecast 2022-2028

When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence, hemostats offer temporary blockage by forming blood clot to control bleeding.
This report contains market size and forecasts of Hemostat Powder and Hemostatic Agents in global, including the following market information:
Global Hemostat Powder and Hemostatic Agents Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Hemostat Powder and Hemostatic Agents Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Hemostat Powder and Hemostatic Agents companies in 2021 (%)
The global Hemostat Powder and Hemostatic Agents market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Microfibrillar Collagen Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hemostat Powder and Hemostatic Agents include J&J, Baxter, BD, B Braun, Gelita, Integra Life Sciences, Advance Medical Solution, Pfizer and CSL Behring, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hemostat Powder and Hemostatic Agents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hemostat Powder and Hemostatic Agents Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hemostat Powder and Hemostatic Agents Market Segment Percentages, by Type, 2021 (%)
Microfibrillar Collagen
Chitosan
Global Hemostat Powder and Hemostatic Agents Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hemostat Powder and Hemostatic Agents Market Segment Percentages, by Application, 2021 (%)
Minimally Invasive Surgery
Ordinary Surgery
Other
Global Hemostat Powder and Hemostatic Agents Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hemostat Powder and Hemostatic Agents Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hemostat Powder and Hemostatic Agents revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Hemostat Powder and Hemostatic Agents revenues share in global market, 2021 (%)
Key companies Hemostat Powder and Hemostatic Agents sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Hemostat Powder and Hemostatic Agents sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
J&J
Baxter
BD
B Braun
Gelita
Integra Life Sciences
Advance Medical Solution
Pfizer
CSL Behring
CryoLife
Zimmer Biomet
Ferrosan Medical Devices
Medtronic
Smith & Nephew
Z-Medica
Cohera Medical
Marine Polymer
Equimedical

Related Articles

Back to top button